Eric Secemsky (Boston, USA) takes Interventional News through the main highlights of his recently published analyses of a US Medicare claims dataset that examined the association between drug-eluting devices and mortality in peripheral arterial disease patients. Secemsky spoke at the Vascular Leaders Forum, hosted by Vascular Interventional Advances (VIVA), and states that these analyses did not find an association between drug-eluting devices and mortality.
